Serum Clara cell protein (CC16), a marker of the integrity of the air-blood barrier in sarcoidosis Source: Eur Respir J 2001; 18: 507-514 Year: 2001
Serum surfactant protein D (SPD) as a specific marker for COPD Source: Annual Congress 2012 - COPD treatment and varia Year: 2012
Clara cell specific protein (CC16) after LPS inhalation in healthy subjects Source: Annual Congress 2003 - Mechanisms of lung injury: from bench to bedside Year: 2003
Clara cell protein (CC16) in serum and urine after exercise challenge Source: Annual Congress 2012 - Bronchial challenge as a biomarker of respiratory disease Year: 2012
Serum levels of CC16, SP-A and SP-B reflect tobacco-smoke exposure in asymptomatic subjects Source: Eur Respir J 2002; 20: 1152-1161 Year: 2002
Concentration of NO2-, a-acid protein (AAP), tumor necrotic factor (TNF-a), in the induced sputum of patients with bronchial asthma(BA) and chronic obstructive bronchitis (COB) Source: Eur Respir J 2001; 18: Suppl. 33, 367s Year: 2001
Similar sputum secretory leykocyte inhibitor and Clara cell protein 16 levels between current and ex-smokers with COPD Source: Annual Congress 2008 - Basic science in asthma and COPD II Year: 2008
The content of interleukin-4 (IL-4), interferon-γ (IFN-γ) and immunoglobulin A (sIgA) in the exhaled air condensates (EAC) of children with bronchial asthma (BA) Source: Eur Respir J 2007; 30: Suppl. 51, 644s Year: 2007
Clara cell protein (CC16) as a biomarker for ozone exposure in humans Source: Eur Respir J 2002; 20: Suppl. 38, 569s Year: 2002
Serum surfactant protein D (SPD) and response to the combined therapy in patients (pts) with stable COPD Source: Annual Congress 2012 - COPD treatment and varia Year: 2012
Clara cell secretory protein and its mRNA expression in induced sputum of acute bacterial exacerbations of COPD Source: Eur Respir J 2002; 20: Suppl. 38, 543s Year: 2002
Effect of recombinant α-1 antitrypsin (rAAT) and TAPI on neutrophil elastase (NE) and matrix metalloproteinase-9 (MMP9) activity in induced sputum (IS) from healthy smokers and patients with chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2003 - Progress on therapy for chronic obstructive pulmonary disease Year: 2003
The typing of cells in the induced sputum (IS) and its apoptosis in patients with bronchial asthma (BA) Source: Eur Respir J 2002; 20: Suppl. 38, 384s Year: 2002
Levels of alkaline phosphatase (ALP), albumin (ALB) and D dimer (DD) in bronchoalveolar lavage (BAL) in patients with Interstitial lung disease (ILD) Source: Eur Respir J 2002; 20: Suppl. 38, 468s Year: 2002
Early stage asymptomatic (HRCT detectable) patients with IPF showed augmented serum surfactant protein D (SP-D) Source: Eur Respir J 2002; 20: Suppl. 38, 61s Year: 2002
Clara cell protein 16 (CC16) and markers of fibrosis in exogenous toxic (ETA) and exogenous allergic (EAA) alveolites Source: International Congress 2014 – Environment and mechanisms Year: 2014
Interleukin-2 in blood serum (BS), expired air condensate (EAC) and nazal lavage fluid (NLF) in children with bronchial asthma (BA) Source: Eur Respir J 2003; 22: Suppl. 45, 398s Year: 2003
Apoptosis and CD95 receptor in the main cells of induced sputum (IS) in bronchial asthma (BA) and chronic obstructive bronchitis (COB) patients Source: Eur Respir J 2001; 18: Suppl. 33, 502s Year: 2001
Association between serum clara cell secretory protein (CC-16) levels and asthma-related phenotypes among adults from the EGEA study Source: Annual Congress 2012 - Prevalences and characterstics of obstructive airway disease Year: 2012
Steroid-induced BAL lymphocyte (L-BAL) apoptosis as prognostic factor in patients with bronchial asthma (AB) Source: Eur Respir J 2005; 26: Suppl. 49, 281s Year: 2005